UK firm hVIVO has launched a coronavirus antibody testing service for big businesses that it says could help get employees back to work as lockdown eases.
The antibody test is available to UK companies initially, while hVIVO looks into rolling out the testing service to GP surgeries, nursing services, health clinics and private hospitals. For the time being the tests aren’t on offer to individual members of the public.
hVIVO is quick to point out that it has licensed a test from Quotient that is 100% accurate as it uses a blood sample drawn from a vein, and doesn’t rely on finger prick blood.
Open Orphan (LON:ORPH) was founded in 2017, with the goal of rapidly building Europe’s leading pharma services company by a management team with extensive industry and financial expertise. The company comprises of two commercial specialist CRO services businesses (Venn Life Sciences and hVIVO) and is also developing a genomics data platform business (Genomic Health Data).